FOLH1 and neoplasm: It is worth noting that 177Lu-PSMA-617, exhibited similar pharmacokinetics compared to 111In-PSMA-617, which is also characterized by high and retained tumor uptake and almost complete elimination of the radioactivity through kidneys within 24 h [26].